Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 12;12(1):6122.
doi: 10.1038/s41598-022-10004-6.

PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study

Affiliations

PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study

Felicitas J Detmer et al. Sci Rep. .

Abstract

Mitochondrial dysfunction plays a key role in doxorubicin-induced cardiotoxicity (DIC). In this proof-of-principle study, we investigated whether PET mapping of cardiac membrane potential, an indicator of mitochondrial function, could detect an acute cardiotoxic effect of doxorubicin (DOX) in a large animal model. Eight Yucatan pigs were imaged dynamically with [18F](4-Fluorophenyl)triphenylphosphonium ([18F]FTPP+) PET/CT. Our experimental protocol included a control saline infusion into the left anterior descending coronary artery (LAD) followed by a DOX test infusion of either 1 mg/kg or 2 mg/kg during PET. We measured the change in total cardiac membrane potential (ΔΨT), a proxy for the mitochondrial membrane potential, ΔΨm, after the saline and DOX infusions. We observed a partial depolarization of the mitochondria following the DOX infusions, which occurred only in myocardial areas distal to the intracoronary catheter, thereby demonstrating a direct association between the exposure of the mitochondria to DOX and a change in ΔΨT. Furthermore, doubling the DOX dose caused a more severe depolarization of myocardium in the LAD territory distal to the infusion catheter. In conclusion, [18F]FTPP+ PET-based ΔΨT mapping can measure partial depolarization of myocardial mitochondria following intracoronary DOX infusion in a large animal model.

PubMed Disclaimer

Conflict of interest statement

Patent US 11,109,819 B2, ‘System and method for quantitatively mapping mitochondrial membrane potential’ (status: granted) is assigned to The General Hospital Corporation and lists Drs. Alpert, El Fakhri, Guehl and Normandin as inventors. The other authors declare that they have no potential conflict of interest.

Figures

Figure 1
Figure 1
Timeline of saline and DOX infusions during the PET image acquisition for Group A and B.
Figure 2
Figure 2
Mean normalized TACs for two segments of the LAD (top) and two segments of the RCA (bottom) for the eight animals. The grey shaded area indicates the mean + /-standard error. The blue dotted lines indicate the beginning and end of the control saline infusion (C), whereas the orange dotted lines mark the beginning and end of the DOX infusion (D).
Figure 3
Figure 3
Parametric images of ΔΨT before and after the saline (top) as well as the DOX infusion (bottom) for one animal of group A (left) and one animal of group B (right).
Figure 4
Figure 4
Mean (bars) + /- standard error of change in ΔΨT for each of the 16 segments and the three types of “interventions” (saline – “SAL”, DOX 1 mg/kg – “DOX1”, and DOX 2 mg/kg – “DOX2”) averaged over the eight studies. The four segments that had a significantly different change in ΔΨT compared to the other segments are indicated with asterisks.
Figure 5
Figure 5
Mean (bars) + /- standard error of change in ΔΨT for the segments directly exposed to the saline and DOX infusions (a priori defined as segments 7, 8, 13, and 14) as well as the control segments after the saline and DOX infusion (left) and comparison of change in ΔΨT for a dose of 1 mg/kg vs 2 mg/kg (right).

References

    1. Sawaya H, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am. J. Cardiol. 2011;107:1375–1380. doi: 10.1016/j.amjcard.2011.01.006. - DOI - PMC - PubMed
    1. Čelutkienė J, et al. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the heart failure association of the European society of cardiology. Eur. J. Heart Fail. 2018;20:1615–1633. doi: 10.1002/ejhf.1330. - DOI - PubMed
    1. Cardinale D, Cipolla CM. Chemotherapy-induced cardiotoxicity: importance of early detection. Exp. Rev. Cardiovasc. Ther. 2016;14:1297–1299. doi: 10.1080/14779072.2016.1239528. - DOI - PubMed
    1. Menna P, Salvatorelli E. Primary prevention strategies for anthracycline cardiotoxicity: a brief overview. Chemotherapy. 2017;62:159–168. doi: 10.1159/000455823. - DOI - PubMed
    1. Wenningmann N, Knapp M, Ande A, Vaidya TR, Ait-Oudhia S. Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring. Mol. Pharmacol. 2019;96:219. doi: 10.1124/mol.119.115725. - DOI - PubMed

Publication types

MeSH terms